DermTech price target lowered to $6 from $8 at TD Cowen

TD Cowen analyst Max Masucci lowered the firm’s price target on DermTech to $6 from $8 and keeps an Outperform rating on the shares. The analyst said they continueto make progress expanding coverage up 40% quarter-over-quarter, along with generating healthy volume growth up nearly 50% year-over-year though ASPs have remained under pressure.